Opus Genetics, Inc. · NASDAQ:IRD
Gagnon Robert E. sold 7,783 Opus Genetics, Inc. shares (Form 4)
Traded Jul 23, 2026 · Filed Jul 27, 2026
On Jul 23, 2026, Gagnon Robert E. (Chief Financial Officer) sold 7,783 Opus Genetics, Inc. shares at US$2.95 for US$22,960, leaving 584,375 shares. Filed Jul 27, 2026 (Form 4).
- Sold
- 7,783 shares
- Price
- US$2.95
- Value
- US$22,960
- Holding after
- 584,375 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | Sale | 7,783 | US$2.95 | 584,375 | Direct |
Source
Related
- Opus Genetics, Inc.
- Gagnon Robert E.
- Opus Genetics, Inc. shareholders
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Apr 27, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026